Best Practices for ESR1 Mutation Testing in Patients With Breast Cancer
An expert on breast cancer reviews currently available tests for ESR1 mutations and provides clinical insights on best practices for testing.
Source: ajmc.com
Esr1 Mutations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Esr1 Mutations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Esr1 Mutations Today - Breaking & Trending Today
Overview of ESR1 Mutations in ER+/HER2- Metastatic Breast Cancer
Stephanie L. Graff, MD, provides an overview of ESR1 mutations in ER+/HER2- metastatic breast cancer, highlighting their prevalence, clinical implications, and challenges.
Source: ajmc.com
Elacestrant: Adverse Effects and Their Management, and Impact of Treatment on Quality of Life
Experts discuss the impact of elacestrant on patient well-being, including potential cardiovascular and gastrointestinal toxicities, quality of life, and patient feedback regarding access to treatment.
Source: ajmc.com
Elacestrant: Treatment Considerations, Including Dosing and Compliance
Experts explore treatment considerations when treating patients with metastatic breast cancer with elacestrant, including dosing, patient selection, adherence, and treatment duration. Participants also discuss dose modifications, adherence concerns, and how they determine treatment failure.
Source: ajmc.com
Elacestrant in Later-Line Treatment of ER+/HER2– Metastatic Breast Cancer
Experts delve into practical aspects of using elacestrant in later-line treatment of patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer, including testing for ESR1 mutations, evaluating efficacy, and monitoring for toxicity.
Source: ajmc.com